Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

1(17%)

Results Posted

0%(0 trials)

Terminated

1(17%)

Phase Distribution

Ph phase_1

33%

Ph not_applicable

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

2(33.3%)

N/ANon-phased studies

4(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Terminated(1)

Other(1)

Detailed Status

Completed3

unknown1

Terminated1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 1

Trials by Phase

Phase 12 (33.3%)

N/A4 (66.7%)

Trials by Status

unknown117%

completed350%

terminated117%

active_not_recruiting117%

Recent Activity

1 active trials

Showing 5 of 6

active_not_recruitingnot_applicable

Pharmacokinetics of Trans-resveratrol Based Nutritional Supplement and Its Three Metabolites in Human Eyes and Blood

NCT02321176

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT03762096Not Applicable

Short Interval Resveratrol Trial in Cardiovascular Surgery

Active Not Recruiting

NCT04421079Phase 1

Metabolism of Bioactive Dietary Polyphenol Preparation (BDPP)

Completed

NCT02625376Not Applicable

Resveratrol for Exudative Age-Related Macular Degeneration

Terminated

NCT02616822Phase 1

Effects of Trans-Resveratrol in Endothelial Function in Hypertensive Patients

Completed

NCT02321176Not Applicable

Pharmacokinetics of Trans-resveratrol Based Nutritional Supplement and Its Three Metabolites in Human Eyes and Blood

Unknown

NCT01794351Not Applicable

Cognitive Effects of 500mg Trans-resveratrol

Completed

All 6 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 6